S9 Ep13: Midweek Takeaway with James Short, CEO of Celadon Pharmaceuticals (AIM:CEL) #CEL
In this episode of The Midweek Takeaway, we’re joined by James Short, CEO of Celadon Pharmaceuticals. We dive into the company’s exciting news of securing a five-year sales contract worth up to £10.5 million for the supply of medicinal cannabis. James shares details about the contract’s minimum order volumes, the strategic collaboration with Valeos Pharma A/S, and how these developments position Celadon to expand its UK and European operations. With an order book potential of £40.7 million, the future looks promising for Celadon. Tune in to hear more about the company’s plans and what’s next…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.